Aclarion, Inc. (ACONW)

NASDAQ: ACONW · Real-Time Price · USD · Warrants
0.0343
+0.0107 (45.34%)
Jul 17, 2025, 4:00 PM - Market closed
45.34%
Market Cap4.32M
Revenue (ttm)54,601
Net Income (ttm)-6.70M
Shares Out 582.37K
EPS (ttm)-11.50
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume526
Open0.0291
Previous Close0.0236
Day's Range0.0291 - 0.0291
52-Week Range0.0100 - 0.2446
Beta1.21
Analystsn/a
Price Targetn/a
Earnings DateMar 7, 2025

About ACONW

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam;... [Read more]

Sector Healthcare
Founded 2008
Employees 6
Stock Exchange NASDAQ
Ticker Symbol ACONW
Full Company Profile

News

There is no news available yet.